Ginsenoside Rg3 increases gemcitabine sensitivity of pancreatic adenocarcinoma via reducing ZFP91 mediated TSPYL2 destabilization
Open Access
- 30 August 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 46 (5), 636-645
- https://doi.org/10.1016/j.jgr.2021.08.004
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A pathology atlas of the human cancer transcriptomeScience, 2017
- Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancerOncotarget, 2016
- CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaNature Medicine, 2016
- Molecular docking of chemotherapeutic agents to CYP3A4 in non-small cell lung cancerBiomedicine & Pharmacotherapy, 2015
- TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activationCell Death & Differentiation, 2015
- Pancreatic AdenocarcinomaThe New England Journal of Medicine, 2014
- Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based ChemotherapyMolecular Cancer Therapeutics, 2011
- An Atypical E3 Ligase Zinc Finger Protein 91 Stabilizes and Activates NF-κB-inducing Kinase via Lys63-linked UbiquitinationOnline Journal of Public Health Informatics, 2010
- Differentially expressed nucleolar transforming growth factor-β1 target (DENTT) exhibits an inhibitory role on tumorigenesisCarcinogenesis: Integrative Cancer Research, 2008
- Antiproliferative Autoantigen CDA1 Transcriptionally Up-regulates p21Waf1/Cip1 by Activating p53 and MEK/ERK1/2 MAPK PathwaysOnline Journal of Public Health Informatics, 2007